Enanta Pharmaceuticals Inc. sell StockNews.com
Start price
06.04.24
/
50%
€15.20
Target price
06.04.25
-
Performance (%)
-17.11%
Price
26.04.24
€11.40
Summary
This prediction is currently active. The prediction for Enanta Pharmaceuticals Inc. shows a convincing performance of -17.11%. This prediction currently runs until 06.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Enanta Pharmaceuticals Inc. | -8.065% |
| iShares Core DAX® | 0.961% |
| iShares Nasdaq 100 | 2.626% |
| iShares Nikkei 225® | 0.217% |
| iShares S&P 500 | 1.540% |
Comments by StockNews_com for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by StockNews_com for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.70
30.09.23
30.09.23
-
30.09.24
30.09.24
17.76%
26.04.24
26.04.24
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.00
02.09.23
02.09.23
-
02.09.24
02.09.24
-12.31%
26.04.24
26.04.24